跳到正文
原文
Nature 健康护理主题·· 2026-10-08AI 评分60

诊断前肌肉量低下与肌少症同后续癌症相关:中国CHARLS纵向队列研究

Pre-diagnostic low muscle mass and sarcopenia associated with subsequent cancer in Chinese adults: a longitudinal CHARLS study

AI 导读

利用中国健康与养老纵向调查CHARLS 2011–2020年数据,分析45岁及以上无癌症报告人群的肌肉指标与后续首次自报癌症的关联。基线10,407名无癌参与者中,随访期内共254人首次自报癌症。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Loss of skeletal muscle may reflect systemic physiological compromise before cancer is clinically recognized. We examined whether low muscle mass, sarcopenia, and deterioration in these phenotypes were associated with subsequent first self-reported cancer in middle-aged and older Chinese adults. We analyzed China Health and Retirement Longitudinal Study (CHARLS) data from 2011 to 2020. Adults aged 45 years or older who reported no cancer in 2011 were eligible. The primary pre-diagnostic risk set excluded first cancer reports in 2013 or 2015, ensuring that 2015 muscle status preceded cancer reporting in 2018 or 2020. Low muscle mass was defined as height-adjusted appendicular skeletal muscle mass (ASM/height²) < 6.8 kg/m² in men or < 5.69 kg/m² in women. Low muscle strength was defined as grip strength < 28 kg in men or < 18 kg in women. Sarcopenia was identified using the composite c2015_sarcopenia indicator according to the prespecified sarcopenia definition. The analysis variables were c2015_lowmusclemass and c2015_sarcopenia (0 = no, 1 = yes, null=unknown/unavailable). The primary analysis used wave-based Cox regression with censoring at the last observed cancer-status wave. Models adjusted for demographic factors, smoking, drinking, hypertension, diabetes, and dyslipidemia; expanded sensitivity models additionally considered baseline body mass index, estimated glomerular filtration rate, and 2011–2015 weight change. Firth logistic models and a 2020-only longer-lag analysis assessed rare-event robustness. Among 10,407 cancer-free participants at baseline, 254 first reported cancer during follow-up; 212 first reported cancer in 2018 or 2020. Only 22 participants in the pre-diagnostic risk set had cancer status missing at both target waves and were not classified as cancer-free. In the primary Cox models, 2015 low muscle mass (hazard ratio [HR] 2.02, 95% confidence interval [CI] 1.10–3.71; P = 0.023) and sarcopenia (HR 2.33, 95% CI 1.17–4.66; P = 0.016) were associated with later first cancer reporting. Cumulative reporting was 3.39% versus 1.87% for participants with versus without low muscle mass and 4.00% versus 1.90% for those with versus without sarcopenia. In four-level transition models, new/worsened low muscle mass (HR 3.45, 95% CI 1.44–8.25) and new/worsened sarcopenia (HR 4.31, 95% CI 1.80-10.32) showed the strongest associations. The findings remained directionally consistent after expanded confounder adjustment and in longer-lag Firth analyses. Low muscle mass and worsening sarcopenia measured before a first cancer report were associated with subsequent self-reported cancer. Given the low absolute event rates, self-reported outcome, residual confounding, and possibility of occult cancer preceding recognition, these findings support a pre-diagnostic vulnerability phenotype rather than a causal or screening interpretation.

Acknowledgements

We thank the China Health and Retirement Longitudinal Study project team and all study participants for making these data available for research.

Author information

Author notes

  1. Wensi Zhao and Xinyu Wu have contributed equally to this work.

Authors and Affiliations

  1. Department of Oncology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China

    Wensi Zhao, Xinyu Wu, Xiang Cheng & Dedong Cao

  2. Department of Oncology, Taikang Tongji Hospital, Wuhan, 430060, China

    Nan Zhao

  3. Department of Oncology, The Fifth Hospital of Wuhan, Wuhan, 430000, China

    Huilin Xu

Authors

  1. Wensi Zhao
  2. Xinyu Wu
  3. Xiang Cheng
  4. Nan Zhao
  5. Huilin Xu
  6. Dedong Cao

Corresponding author

Correspondence to Dedong Cao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

CHARLS was approved by the Biomedical Ethics Committee of Peking University (IRB00001052-11015). All participants or their representatives provided informed consent before data collection. The present study used de-identified secondary data.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, W., Wu, X., Cheng, X. et al. Pre-diagnostic low muscle mass and sarcopenia associated with subsequent cancer in Chinese adults: a longitudinal CHARLS study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-74449-9

Download citation

  • Received: 13 June 2026

  • Accepted: 29 September 2026

  • Published: 08 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-74449-9

Keywords

来源:Nature 健康护理主题 · nature.com